Lilly, Resilience to Invest $750 Million in U.S. Drug Manufacturing Expansion
Drugmaker Eli Lilly and privately held contract manufacturer Resilience are investing $750 million to expand pharmaceutical manufacturing capacity in the U.S., aiming to strengthen the domestic medicine supply chain.3 sourcesSee all sources